Heartseed Doses First Patient in Historic iPSC-Derived Cardiomyocyte Trial Via Catheter
The company's lead program, HS-001, required open heart surgery, while the new innovation allows for a much simpler, less invasive administration.
Cardiovascular
Trailhead Biosystems Expands iPSC-Derived Cell Portfolio With TrailBio Endothelial Cells
Trailhead Biosystems has launched a functionally validated, highly pure iPSC-derived endothelial cell product designed to give researchers a scalable, reproducible human vascular model for angiogenesis, inflammation, drug screening and toxicity studies.
Longeveron Nabs Patent for Stem Cell Testing Techniques in Japan
With the right secured for stem cell potency, Longeveron is continuing its path forward with clinical trials for several mesenchymal stem cell indications.
Cellistic Unveils New Induced Pluripotent Stem Cell Manufacturing Platforms for Cancer and Regenerative Therapies
The new platforms aim to streamline large-scale production of iPSC-derived cell therapies for new indications.
Mayo Clinic Develops Stem Cell Patch to Potentially Repair Heart Damage Without Surgery
Researchers are testing a minimally invasive stem cell patch that could reduce the need for transplants.
Potential Retraction Coming on Pivotal Phase 3 Stem Cell Trial for Heart Failure
What appeared to be a potential stem cell breakthrough is slowly being torn apart by peer-reviewers, who found damning inconsistencies in the data.
Celularity Reports Phase 2 Trial Results on Placenta-Derived Cell Therapy for Diabetic Foot Ulcers with Peripheral Artery Disease
The Phase 2 study showed good results for placenta-derived cell therapy for diabetic foot ulcers complicated by PAD.
RoosterBio Helping Secretome Therapeutics Scale Cardiac Cell Therapy Manufacturing
RoosterBio and Secretome advance scalable cell therapy manufacturing with a new 50L bioreactor process for STM-01 clinical trials.
Capricor Therapeutics Announces FDA Type A Meeting to Discuss Duchenne Muscular Dystrophy Treatment Path
Capricor Therapeutics is coordinating with the FDA on regulatory steps for its Duchenne therapy, with updates expected soon.
New Trial: Mesenchymal Stem Cell Exosomes for Preventing and Treating Organ Failure After Aortic Dissection Surgery
Researchers in China are testing whether exosomes can help prevent or treat organ failure after aortic dissection surgery.
